Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

3 Marijuana Stocks to Buy Now

By Chris Tyler, InvestorPlace Contributor
The promise of long-term growth in ACB, TLRY and IIPR is there, but making money in marijuana stocks in today’s speculative market comes down to buying and selling smartly.

Global Legalization Will Determine the Fate of Aurora Stock

By Vince Martin, InvestorPlace Contributor
Aurora's broad reach will make it a leader if global legalization accelerates -- and a loser if it doesn't.

3 Consumer Stocks Loading up on Marijuana

By Aaron Levitt, InvestorPlace Contributor
Interest among marijuana stocks is surging from big-name players. These three consumer product firms are the latest to signal their intentions in the cannabis sector.

Tilray Prepares a Second Act That Could Rekindle TLRY Stock

By James Brumley, InvestorPlace Feature Writer
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.

3 Reasons Cronos Group Stock Deserves A Buy Rating

By Will Ashworth, InvestorPlace Contributor
Cronos currently has a market cap of $5.4 billion. In the first quarter, it closed the Altria investment. At the end of March, it had $1.8 billion in cash on the balance sheet. CRON stock is trading at less than 3x cash.

Can Vaping Growth Help Investors Extract More Value From Aphria Stock?

By Will Ashworth, InvestorPlace Contributor
Aphria's interim CEO recognizes that vape products are growing while dried flower is slowing. That trend is one of the multiple catalysts likely to fuel APHA stock in the next year.

Aurora Cannabis Stock: Strong Potential, But This Isn’t the Time to Buy

By Thomas Niel, InvestorPlace Contributor
Aurora Cannabis is making smarts moves globally, but the risks of oversupply and lack of strong American catalyst signal caution for investors.

7 Penny Marijuana Stocks That Are NOT Cheap Stocks

By Mark Putrino, CMT
Just because a stock is a penny stock doesn't mean it is a good buy. The assets may be less than the liabilities and the company may be worthless.

A Simple Test to Find IPO Stocks to Buy

By InvestorPlace Research Staff
Beyond Meat (BYND) was one of the flashiest IPO stocks of the year, but as a group they are outpacing the broader market 2-to-1.

KERN Stock: What Happened, and What’s Next

By InvestorPlace Research Staff
Akerna (KERN) caused quite a bit of excitement in the pot stock community last week. Its meteoric rise might have looked magical – or like a fluke. But, in fact, KERN stock’s success has been a long time coming.

3 Marijuana ETFs to Buy for Safer Cannabis-Based Gains

By Aaron Levitt, InvestorPlace Contributor
Marijuana stocks could be great long-term investments. However, they are still a risky bet. These marijuana ETFs make owning them a little less dangerous.

Canopy Growth Stock Could Drop to $30

By Mark Putrino, CMT
Here is something that Canopy Growth Corp investors should be concerned about after CGC stock's latest earnings report.

Why Has Tilray Stock Been Such a Buzzkill?

By Mark Putrino, CMT
Tilray stock has been a dissappointment to investors. I'm no guru, but I don't think that will change anytime soon.

CBD Oil: The True Power of a Consumer Craze

By InvestorPlace Research Staff
Whether you have tried CBD oil or not, millions of people have. I think you’re going to like the numbers on this one. Here’s the latest on the CBD craze.

4 Top Marijuana Penny Stocks to Take Seriously in 2019

By Josh Enomoto, InvestorPlace Contributor
The U.S.-China trade war makes a strong case for buying marijuana penny stocks as full legalization provides an easy catalyst for economic activity and growth.

This Is Why a REIT Could Be Great for Canopy Growth Stock

By Aaron Levitt, InvestorPlace Contributor
There could be a Canopy Growth REIT coming to a portfolio near you sooner than later. That could be wonderful news for CGC stock investors for the long haul.

Why Aurora Cannabis Stock Has Upside to $10

By Luke Lango, InvestorPlace Senior Investment Analyst
Long-term growth fundamentals provide support for ACB stock at $10, and near-term catalysts provide the firepower for a late 2019 rally.

Why Canopy Growth Stock Is the Perfect Pick for a Short

By Chris Tyler, InvestorPlace Contributor
Despite what others are saying about Canopy Growth, "the best investable opportunity" in CGC stock may be to short shares.

How Marijuana Legalization in Illinois Opens Up a Billion-Dollar Market

By InvestorPlace Research Staff
News flash to anyone who still thinks that marijuana legalization bills are doomed: Illinois just proved you wrong.
Load More